Philip Morris International (PMI) is selling inhaled drug specialist Vectura to Molex Asia Holdings for a fraction of the £1.1 billion ($1.45 billion) it paid for the business three years ago. The ...

Doug Wintemute is a staff writer for Forbes Advisor. After completing his master’s in English at York University, he began his writing career in the higher education space. Over the past decade, Doug ...

Julia Hawley is a full-time writer focusing on investing. She combines her writing skills with her experience in personal wealth management. Katie Miller is a consumer financial services expert. She ...